IGF BINDING PROTEIN-4, PROTEIN-5 AND PROTEIN-6 MAY PLAY SPECIALIZED ROLES DURING L6 MYOBLAST PROLIFERATION AND DIFFERENTIATION

被引:68
作者
EWTON, DZ
FLORINI, JR
机构
关键词
D O I
10.1677/joe.0.1440539
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
It is well known that IGFs-I and -II stimulate both the proliferation and differentiation of myoblasts, but the role of the IGF binding proteins (IGFBPs) during these processes has not been established. In this study we show that IGF-I analogs with greatly reduced affinity for IGFBPs exhibited about a 10-fold increase in potency in stimulating proliferation (as in other cell types), but up to a 100-fold greater potency than native IGF-I in stimulating L6A1c differentiation. Analysis of conditioned media revealed that L6 cells secrete significant levels of IGFBPs that react with antisera to IGFBP-4, -5 and -6. Steady-state levels of IGFBP-4 mRNA were highest in proliferating myoblasts, while IGFBP-5 mRNA could not be detected in myoblasts although its levels were dramatically increased during IGF- or insulin-stimulated differentiation of myoblasts into myotubes. Elevated IGFBP-6 mRNA levels were found in quiescent cells in serum-free medium. IGF-I and IGF-II treatment elevated IGFBP-5 in conditioned media, but longR (3)IGF-I and insulin, which do not bind to IGFBPs, had smaller effects. This complex regulation of expression of different IGFBPs not only during different stages of muscle growth and differentiation, but also upon stimulation by IGFs or insulin, suggests that the IGFBPs play a specific and significant role in modulating the actions of the IGFs during myogenesis.
引用
收藏
页码:539 / 553
页数:15
相关论文
共 50 条
  • [1] ANDRESS DL, 1992, J BIOL CHEM, V267, P22467
  • [2] RAT PC12 PHEOCHROMOCYTOMA CELLS SYNTHESIZE INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-6
    BACH, LA
    TSENG, LYH
    SWARTZ, JE
    RECHLER, MM
    [J]. ENDOCRINOLOGY, 1993, 133 (03) : 990 - 995
  • [3] BACH LA, 1994, GROWTH REGULATION S1, V4, P90
  • [4] NATURAL AND SYNTHETIC FORMS OF INSULIN-LIKE GROWTH FACTOR-I (IGF-1) AND THE POTENT DERIVATIVE, DESTRIPEPTIDE IGF-1 - BIOLOGICAL-ACTIVITIES AND RECEPTOR-BINDING
    BALLARD, FJ
    FRANCIS, GL
    ROSS, M
    BAGLEY, CJ
    MAY, B
    WALLACE, JC
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 149 (02) : 398 - 404
  • [5] BEGUINOT F, 1985, J BIOL CHEM, V260, P15982
  • [6] [LEU27] INSULIN-LIKE GROWTH FACTOR-II IS HIGHLY SELECTIVE FOR THE TYPE-II IGF RECEPTOR IN BINDING, CROSS-LINKING AND THYMIDINE INCORPORATION EXPERIMENTS
    BEUKERS, MW
    OH, Y
    ZHANG, HP
    LING, N
    ROSENFELD, RG
    [J]. ENDOCRINOLOGY, 1991, 128 (02) : 1201 - 1203
  • [7] CAMACHOHUBNER C, 1992, J BIOL CHEM, V267, P11949
  • [8] SERUM HALF-LIFE AND BIOLOGICAL-ACTIVITY OF MUTANTS OF HUMAN INSULIN-LIKE GROWTH FACTOR-I WHICH DO NOT BIND TO SERUM BINDING-PROTEINS
    CASCIERI, MA
    SAPERSTEIN, R
    HAYES, NS
    GREEN, BG
    CHICCHI, GG
    APPLEBAUM, J
    BAYNE, ML
    [J]. ENDOCRINOLOGY, 1988, 123 (01) : 373 - 381
  • [9] MUTANTS OF HUMAN INSULIN-LIKE GROWTH FACTOR-I WITH REDUCED AFFINITY FOR THE TYPE-1 INSULIN-LIKE GROWTH-FACTOR RECEPTOR
    CASCIERI, MA
    CHICCHI, GG
    APPLEBAUM, J
    HAYES, NS
    GREEN, BG
    BAYNE, ML
    [J]. BIOCHEMISTRY, 1988, 27 (09) : 3229 - 3233
  • [10] CASCIERI MA, 1989, J BIOL CHEM, V264, P2199